$103 Million is the total value of Blue Water Life Science Advisors, LP's 8 reported holdings in Q2 2024. The portfolio turnover from Q1 2024 to Q2 2024 was 25.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
NTRA | NATERA INC | $54,480,049 | +18.4% | 503,094 | 0.0% | 52.98% | +22.4% | |
GH | GUARDANT HEALTH INC | $16,491,837 | +40.0% | 571,047 | 0.0% | 16.04% | +44.7% | |
AKYA | AKOYA BIOSCIENCES INC | $10,992,817 | -50.1% | 4,697,785 | 0.0% | 10.69% | -48.4% | |
CDNA | New | CAREDX INC | $7,920,300 | – | 510,000 | +100.0% | 7.70% | – |
TXG | Buy | 10X GENOMICS INC | $4,473,500 | -38.7% | 230,000 | +18.3% | 4.35% | -36.6% |
QTRX | Sell | QUANTERIX CORP | $3,677,572 | -49.5% | 278,393 | -9.9% | 3.58% | -47.8% |
EXAS | EXACT SCIENCES CORP | $2,422,742 | -38.8% | 57,343 | 0.0% | 2.36% | -36.8% | |
MAXCYTE INC | $2,367,433 | -6.4% | 603,937 | 0.0% | 2.30% | -3.3% | ||
ADPT | Exit | ADAPTIVE BIOTECHNOLOGIES COR | $0 | – | -1,687,665 | -100.0% | -5.10% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2024-08-09
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
NATERA INC | 15 | Q2 2024 | 53.0% |
GUARDANT HEALTH INC | 15 | Q2 2024 | 21.3% |
AKOYA BIOSCIENCES INC | 11 | Q2 2024 | 23.4% |
ADAPTIVE BIOTECHNOLOGIES COR | 10 | Q1 2024 | 17.7% |
CAREDX INC | 8 | Q2 2024 | 19.0% |
MAXCYTE INC | 8 | Q2 2024 | 11.8% |
THERMO FISHER SCIENTIFIC INC | 6 | Q4 2023 | 16.0% |
BIO-TECHNE CORP | 5 | Q3 2022 | 8.8% |
SOMALOGIC INC | 5 | Q3 2022 | 3.8% |
CYTEK BIOSCIENCES INC | 4 | Q1 2023 | 12.5% |
View Blue Water Life Science Advisors, LP's complete holdings history.
Latest filings
Type | Filed |
---|---|
N-PX | 2024-08-30 |
SC 13G | 2024-08-28 |
13F-HR | 2024-08-09 |
13F-HR | 2024-05-15 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
View Blue Water Life Science Advisors, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.